In partnership with patient and NHS organisations we have developed an eosinophilic oesophagitis (EoE) integrated care pathway, a costed integrated patient scenario, prescribing guidance and a shared care protocol. Supporting this content we have created an infographic and videos to explain EoE causing food bolus obstruction to raise awareness of the condition, cover the impact it has on patients and the health service and provide guidance on the optimal management as determined by a consensus group of clinicians.

What is eosinophilic oesophagitis?

Eosinophilic oesophagitis (EoE) is a chronic inflammatory condition of the oesophagus, in which the body overproduces a type of white blood cell called eosinophils, leading to inflammation in the oesophagus.1,2

Patients with EoE typically have the condition for many years and symptoms can be unpleasant and socially embarrassing and have a significant impact on quality of life.2

Once initially regarded as a disease of younger people, EoE is now known to present at any age. The incidence rises during adolescence and peaks in early adulthood.3 In about one third of people, the first episode of EoE is an acute food bolus obstruction,1 requiring emergency hospital attendance.

Failure to diagnose and effectively treat eosinophilic oesophagitis is a barrier to optimal patient care

It is clear that failure to diagnose EoE in patients presenting to accident and emergency (A&E) is a serious barrier to optimal patient care, resulting in a cycle of persistent episodes of food bolus obstructions. 

References:

  1. Dhar A, Haboubi HN, Attwood SE, et al. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut 2022;71:1459–87.
  2. National Institute for Health and Care Excellence (NICE). Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis. Available at: https://www.nice.org.uk/guidance/ta708. Accessed February 2024. 
  3. Dellon ES. Eosinophilic esophagitis (EoE). Available at: www.med.unc.edu/medicine/news/chairs-corner/podcast/eoedellon. Accessed February 2024.

 

 

Interested in improving care pathways in your therapy area?

Get in touch with our team at advisory@hsjinformation.co.uk